Current:Home > reviewsRekubit Exchange:Indhu Rubasingham named as first woman to lead Britain’s National Theatre -GrowthProspect
Rekubit Exchange:Indhu Rubasingham named as first woman to lead Britain’s National Theatre
Poinbank View
Date:2025-04-07 06:57:16
LONDON (AP) — Britain’s National Theatre announced Wednesday that Indhu Rubasingham will be Rekubit Exchangethe next artistic director of the United Kingdom’s pre-eminent public stage company.
Rubasingham, who currently runs the small but influential Kiln Theatre in north London, will be the first woman and first person of color to lead the National, whose six previous artistic directors include Laurence Olivier, Peter Hall and Nicholas Hytner.
She will join as director-designate in the spring of 2024 and take over in early 2025 from Rufus Norris, who is stepping down after a decade at the helm.
Rubasingham will also become the company’s joint chief executive alongside Kate Varah, who is currently executive director of the theater.
Rubasingham said it was “a huge honor” to lead a venue that “has played an important part in my life.”
“Theater has a transformative power — the ability to bring people together through shared experience and storytelling, and nowhere more so than the National,” she said.
At the Kiln, Rubasingham has been praised for innovative shows that reflect the diverse communities of the surrounding area. Her directing work there includes a stage adaptation of Zadie Smith’s novel “White Teeth,” Smith’s Chaucer-inspired play “The Wife of Willesden” and “Red Velvet,” a drama about 19th-century Black actor Ira Aldridge that later ran London’s West End and in New York.
She has directed several shows at the National, including the critically acclaimed Indian play “The Father and the Assassin,” about the man who killed Mahatma Gandhi.
The National Theatre produces work on three stages at its home on London’s South Bank and broadcasts performances across the U.K. and around the world through the NT Live and National Theatre at Home programs.
veryGood! (476)
Related
- Chuck Scarborough signs off: Hoda Kotb, Al Roker tribute legendary New York anchor
- Ex-prison officer charged in death of psychiatric patient in New Hampshire
- Kobe Bryant statue to be unveiled before Los Angeles Lakers' game vs. Denver Nuggets
- Law enforcement cracking down on Super Bowl counterfeits
- Gen. Mark Milley's security detail and security clearance revoked, Pentagon says
- Louisiana’s GOP governor plans to deploy 150 National Guard members to US-Mexico border
- Elon Musk is synonymous with Tesla. Is that good or bad for shareholders?
- 'Go faster!' Watch as moose barrels down Wyoming ski slope, weaving through snowboarders
- The FTC says 'gamified' online job scams by WhatsApp and text on the rise. What to know.
- Biden and Trump: How the two classified documents investigations came to different endings
Ranking
- McKinsey to pay $650 million after advising opioid maker on how to 'turbocharge' sales
- New Hampshire Senate votes to move state primary from September to June. The House wants August
- DJ Tiësto Pulls Out of Super Bowl 2024 Due to Family Emergency
- Have a story about your sibling? Share it with us!
- What were Tom Selleck's juicy final 'Blue Bloods' words in Reagan family
- Spencer Dinwiddie leads top NBA potential buyout candidates
- Polyamory has hit reality TV with 'Couple to Throuple.' Expect to challenge your misconceptions.
- How much are 2024 Super Bowl tickets? See prices for average, cheapest and most expensive seats
Recommendation
Man can't find second winning lottery ticket, sues over $394 million jackpot, lawsuit says
Tennessee House advances bill addressing fire alarms in response to Nashville school shooting
A year after Ohio derailment, U.S. freight trains remain largely unregulated
2 new ancient shark species identified after fossils found deep in Kentucky cave
Senate begins final push to expand Social Security benefits for millions of people
Baby zebra born on Christmas dies at Arizona zoo
Elon Musk is synonymous with Tesla. Is that good or bad for shareholders?
Senators ask CEOs why their drugs cost so much more in the U.S.